eGnome has pioneered a 3rd-generation microbiome analysis software, "EG-Mirror," achieving 99.9% accuracy in disease risk prediction. EG-Mirror analyzes the full rRNA operon, providing 10 times more information than previous methods and precisely distinguishing between beneficial and harmful bacteria for tailored health solutions. The research has been published in Microbiology Spectrum, and technology transfers are underway in Japan and other countries. This innovation is set to establish a new standard in personalized healthcare and precision medicine.